OCX insider buying – Oncocyte Corp
45 insider purchases since 2016 worth $119.5M by 17 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2025-02-11.
Where insiders bought and sold OCX – last 5 yearsCEO / officers Directors Funds & 10% owners Sales
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 16 older purchases (before the 5-year window) are listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| ANDREWS RONALD ASBURY CEO | $43.0M 5× · 186,216 sh | 2020-03-30 2022-08-16 | – | 583,212 shares as of 2022-12-09 | Holds - never sold |
| BROADWOOD PARTNERS, L.P. 10% Owner | $39.0M 6× · 43,417,085 sh | 2019-07-02 2025-02-06 | – | 50,159,930 shares as of 2026-04-27 | Holds - never sold |
| BROADWOOD CAPITAL INC 10% Owner | $13.6M 4× · 6,416,926 sh | 2018-03-28 2024-10-02 | – | 48,296,616 shares as of 2026-04-20 | Holds - never sold |
| BRADSHER NEAL C 10% Owner | $12.4M 4× · 5,078,217 sh | 2019-11-13 2021-01-20 | – | 23,863,835 shares as of 2026-02-12 | Holds - never sold |
| PURA VIDA INVESTMENTS, LLC 10% Owner | $8.1M 2× · 6,594,707 sh | 2022-04-14 2023-04-05 | 1× · $102,837 last 2022-06-24 | 14,166,163 shares as of 2023-04-18 | Holds (sold earlier) |
| SMITH PATRICK W 10% Owner | $2.4M 3× · 1,183,874 sh | 2024-12-26 2025-02-07 | – | 2,872,671 shares as of 2025-02-11 | Holds - never sold |
| Arno Andrew Director | $479,495 6× · 511,398 sh | 2019-09-17 2024-12-26 | – | 164,589 shares as of 2026-07-06 | Holds - never sold |
| James Andrea S. CFO | $345,800 3× · 151,231 sh | 2024-10-02 2025-02-07 | – | 206,060 shares as of 2026-03-30 | Holds - never sold |
| Levine Mitchell S CFO | $62,550 3× · 45,000 sh | 2019-09-12 2022-03-15 | – | 87,080 shares as of 2022-03-15 | Holds - never sold |
| Gutfreund John Peter Director | $48,000 2× · 100,000 sh | 2022-08-15 2022-12-23 | – | 715,000 shares as of 2023-07-03 | Holds - never sold |
| Redmond Cavan M. Director | $47,600 1× · 40,000 sh | 2022-03-16 2022-03-16 | – | 120,863 shares as of 2022-07-19 | Holds - never sold |
| Ross Douglas T. Officer | $21,000 1× · 15,000 sh | 2022-03-25 2022-03-25 | – | 234,114 shares as of 2022-12-22 | Holds - never sold |
| Paulsen Gisela Officer | $19,800 1× · 16,500 sh | 2022-03-17 2022-03-17 | – | 366,500 shares as of 2022-12-20 | Holds - never sold |
| KALAJIAN TONY T Officer | $19,800 1× · 10,000 sh | 2019-09-13 2019-09-13 | – | 15,000 shares as of 2020-08-05 | Holds - never sold |
| Last Andrew J. Director | $17,400 1× · 20,000 sh | 2022-08-17 2022-08-17 | – | 58,752 shares as of 2026-07-06 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2025 | 4 | $13.0M | 3 | – | – |
| 2024 | 8 | $11.4M | 6 | – | – |
| 2023 | 2 | $8.2M | 2 | – | – |
| 2022 | 15 | $16.4M | 11 | 1 | $102,837 |
| 2021 | 3 | $7.7M | 3 | – | – |
| 2020 | 5 | $48.2M | 3 | 1 | $5.1M |
| 2019 | 7 | $9.5M | 6 | 2 | $11.1M |
| 2018 | 1 | $5.0M | 1 | – | – |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2025-02-11 | SMITH PATRICK W | 10% Owner | 1,077,600 | $2.05 | $2.2M | +60.0% | SEC |
| 2025-02-11 | James Andrea S. | CFO | 97,561 | $2.05 | $200,000 | +181.8% | SEC |
| 2025-02-10 | BROADWOOD PARTNERS, L.P. | 10% Owner | 5,165,695 | $2.05 | $10.6M | +82.7% | SEC |
| 2025-01-15 | SMITH PATRICK W | 10% Owner | 16,055 | $2.12 | $34,114 | +0.9% | SEC |
| 2024-12-27 | SMITH PATRICK W | 10% Owner | 90,219 | $2.13 | $192,166 | +5.4% | SEC |
| 2024-12-26 | Arno Andrew | Director | 12,500 | $2.11 | $26,375 | +18.1% | SEC |
| 2024-12-09 | James Andrea S. | CFO | 20,000 | $2.29 | $45,800 | +59.4% | SEC |
| 2024-10-04 | James Andrea S. | CFO | 33,670 | $2.97 | $100,000 | SEC | |
| 2024-10-04 | BROADWOOD CAPITAL INC | 10% Owner | 1,315,339 | $2.95 | $3.9M | +26.7% | SEC |
| 2024-04-15 | Riggs Josh | CEO | 3,390 | $2.95 | $10,000 | +2947.8% | SEC |
| 2024-04-15 | BROADWOOD PARTNERS, L.P. | 10% Owner | 2,420,000 | $2.92 | $7.1M | +96.5% | SEC |
| 2024-04-15 | Arno Andrew | Director | 33,898 | $2.95 | $99,999 | +96.4% | SEC |
| 2023-04-07 | PURA VIDA INVESTMENTS, LLC | 10% Owner | 663,000 | $0.30 | $198,900 | +8.9% | SEC |
| 2023-04-05 | BROADWOOD PARTNERS, L.P. | 10% Owner | 26,827,638 | $0.30 | $8.0M | +114.9% | SEC |
| 2022-12-28 | Gutfreund John Peter | Director | 75,000 | $0.33 | $24,750 | SEC | |
| 2022-12-28 | Arno Andrew | Director | 250,000 | $0.35 | $87,500 | +88.6% | SEC |
| 2022-08-19 | Last Andrew J. | Director | 20,000 | $0.87 | $17,400 | +39.9% | SEC |
| 2022-08-19 | Arno Andrew | Director | 15,000 | $0.90 | $13,500 | SEC | |
| 2022-08-18 | ANDREWS RONALD ASBURY | CEO | 40,000 | $0.96 | $38,400 | +13.6% | SEC |
| 2022-08-17 | GRIFFITH MELINDA | Director | 10,000 | $1.00 | $10,000 | +50.0% | SEC |
| 2022-08-17 | Gutfreund John Peter | Director | 25,000 | $0.93 | $23,250 | SEC | |
| 2022-08-17 | Arno Andrew | Director | 150,000 | $0.96 | $144,121 | +113.6% | SEC |
| 2022-04-18 | PURA VIDA INVESTMENTS, LLC | 10% Owner | 5,931,707 | $1.33 | $7.9M | +228.1% | SEC |
| 2022-04-15 | BROADWOOD PARTNERS, L.P. | 10% Owner | 6,003,752 | $1.33 | $8.0M | +34.6% | SEC |
| 2022-03-28 | Ross Douglas T. | Officer | 15,000 | $1.40 | $21,000 | +282.1% | SEC |
| 2022-03-17 | Paulsen Gisela | Officer | 16,500 | $1.20 | $19,800 | SEC | |
| 2022-03-17 | ANDREWS RONALD ASBURY | CEO | 50,000 | $1.28 | $64,000 | +20.6% | SEC |
| 2022-03-16 | Redmond Cavan M. | Director | 40,000 | $1.19 | $47,600 | +56.4% | SEC |
| 2022-03-15 | Levine Mitchell S | CFO | 25,000 | $1.17 | $29,250 | +40.3% | SEC |
| 2021-03-22 | ANDREWS RONALD ASBURY | CEO | 11,000 | $4.79 | $52,690 | +10.7% | SEC |
| 2021-02-09 | BROADWOOD CAPITAL INC | 10% Owner | 600,000 | $4.50 | $2.7M | +3.7% | SEC |
| 2021-01-22 | BRADSHER NEAL C | 10% Owner | 1,460,280 | $3.42 | $5.0M | +9.9% | SEC |
| 2020-08-04 | Levine Mitchell S | CFO | 10,000 | $1.32 | $13,200 | +37.6% | SEC |
| 2020-08-04 | ANDREWS RONALD ASBURY | CEO | 40,000 | $1.35 | $54,000 | +63.8% | SEC |
| 2020-04-28 | BRADSHER NEAL C | 10% Owner | 1,050,000 | $2.27 | $2.4M | +7.7% | SEC |
| 2020-04-01 | ANDREWS RONALD ASBURY | CEO | 45,216 | $945.63 | $42.8M | +258.6% | SEC |
| 2020-01-06 | BRADSHER NEAL C | 10% Owner | 1,391,466 | $2.16 | $3.0M | +11.3% | SEC |
| 2019-11-15 | BRADSHER NEAL C | 10% Owner | 1,176,471 | $1.70 | $2.0M | +10.6% | SEC |
| 2019-09-18 | Arno Andrew | Director | 50,000 | $2.16 | $108,000 | +95.3% | SEC |
| 2019-09-16 | KALAJIAN TONY T | Officer | 10,000 | $1.98 | $19,800 | SEC |
Showing the latest 40 of 45 purchases.
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2022-06-28 | PURA VIDA INVESTMENTS, LLC | 10% Owner | 99,386 | $1.03 | $102,837 | Sale | SEC |
| 2020-01-06 | Lineage Cell Therapeutics, Inc. | Other | 2,383,090 | $2.16 | $5.1M | Sale | SEC |
| 2019-09-13 | Lineage Cell Therapeutics, Inc. | 10% Owner | 4,000,000 | $1.66 | $6.6M | Sale | SEC |
| 2019-07-05 | BIOTIME INC | 10% Owner | 2,250,000 | $2.00 | $4.5M | Sale | SEC |
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free